BackDuopharma Biotech Berhad Overview

Duopharma Biotech Berhad Total Liabilities

Duopharma Biotech Berhad's total liabilities is $570M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$574.71M
↓ 18.68% YoYΔ $-132.00M vs prior year quarter

Peer trimmed avg / median

Loading

Duopharma Biotech Berhad Total Liabilities History

Loading

Duopharma Biotech Berhad vs. peers: Total Liabilities Comparison

Loading

Duopharma Biotech Berhad Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Duopharma Biotech Berhad (7148.KL) FAQ

Duopharma Biotech Berhad's total liabilities stands at $570M as of September 2026. That compares with $710M in the prior-year period — down 18.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Duopharma Biotech Berhad reported $570M in total liabilities versus $710M a year earlier — a 18.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $710M in the prior-year period — down 18.7% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Duopharma Biotech Berhad's total liabilities evolved across reporting periods, while the comparison chart places 7148.KL next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers